Clinical trial
Impact of Immunosuppressive Regimens on Polyomavirus-related Transplant…
NCT00160966 · University of Giessen, Other · Completed
Key facts
| NCT number | NCT00160966 |
|---|---|
| Title | Impact of Immunosuppressive Regimens on Polyomavirus-related Transplant Nephropathy |
| Official title | Prospective Randomized Study to Characterize Risk Factors of Polyomavirus-related Transplant Nephropathy and the Impact of Three Immunosuppressive Regimens on Nephropathy Incidence |
| Lead sponsor | University of Giessen, Other |
| Collaborators | Heidelberg University Hoffmann-La Roche Industry Astellas Pharma Inc Novartis |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Polyomavirus Infections |
| Intervention type | Drug |
| Interventions | Ciclosporin and Mycophenolate-mofetil, Tacrolimus and Mycophenolate-mofetil, Tacrolimus and Mycophenolate-mofetil with change from Mycophenolate-mofetil to Everolimus |
| Enrollment | 108 |
| Start date | Sep 1, 2004 |
| Primary completion | Mar 1, 2010 |
| Completion | Mar 1, 2010 |
| First posted | Sep 12, 2005 |
| Last update posted | Mar 28, 2017 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: